Scientific Board

Prof. Dr. Koen Kas

Prof. Dr. Koen Kas

Koen Kas is a biotech entrepreneur with more than 20 years of experience in life sciences. He is founding CEO of InBioVeritas, trendspotting developments at the crossroads of biology, genomic medicine, ICT and social media. He uses these insights in different advisory roles facilitating innovative disruptions in healthcare. He has been the Chief Scientific Officer Oncology of Thrombogenics, a biopharmaceutical company focused on developing innovative medicines for ophthalmic and oncology applications. For the Foundation Fournier-Majoie, he supervises the allocation of a Eur 20M budget to innovative research projects which contribute to advances in cancer management. Koen was founding CEO & CSO of Pronota, a company committed to better diagnosis and personalized medicine in the areas of ovarian cancer, preeclampsia, cardio-renal failure & sepsis. Prior to that, he was Director drug discovery at Galapagos. Previously, he set up and directed the Cancer drug discovery program at Tibotec (now Johnson & Johnson).

Prof. Dr. Andrea Nemeth

Prof. Dr. Andrea Nemeth

Dr Andrea NĂ©meth, MD, PhD, is a Clinician Scientist at the University of Oxford, and a Consultant in Neurogenetics at the Oxford University Hospitals NHS Trust. She trained at the Royal Free Hospital School of Medicine, and also undertook an intercalated BSc in Biochemistry and Neuropharmacology at the Royal Free and University College London. She then moved to Professor Kay Davies lab in Oxford as an MRC Clinical Training Fellow, completing her DPhil at the University of Oxford in 1995. Following this she was awarded a prestigous MRC Clinician Scientist Fellowship which she did at the Wellcome Trust Centre for Human Genetics in Oxford, and during this time developed her interest in ataxias, going on to characterise several novel genetic ataxia syndromes. Dr Nemeth completed her clinical training in Genetics while a Clinical Lecturer at the University of Oxford before becoming a Consultant in Neurogenetics and joining the NDCN.

Dr. Mala Isrie

Mala Isrie, MD

Mala Isrie is a clinical geneticist in training at the VU medical center in Amsterdam. She received her medical degree from Leiden University in 2008. Subsequently, she gained experience in genetic counseling at the Radboud University medical center in Nijmegen as well as the Sir Ganga Ram Hospital in New Delhi. In 2010, she started her PhD at the University of Leuven, where she got trained into the workflow of high-throughput sequencing and contributed to the discovery of some novel genes linked to intellectual disability. Mala is connected to Diploid since 2014. She is particularly interested in the clinical and research applications of genetics for congenital and intellectual disorders, both in Western as well as developing countries.

Dr. Vincent Merckx

Dr. Vincent Merckx

Vincent Merckx holds a Ph.D. from the University of Leuven. He did his post-doc research at UC Berkeley, and is currently working as an evolutionary biologist at the Naturalis Biodiversity Center in Leiden, the Netherlands. His main focus is on phylogenetic reconstruction, application of molecular clock techniques and biogeography. While he applies these techniques on heterotrophic plants, his expertise is equally applicable to other organisms including humans. Vincent is a talented science communicator, teaching classes at the universities of Leiden, Amsterdam and Leuven. As a key advisor for Diploid, he focuses on our science communication and on general strategic directions.